Hoogstraat, Marlous http://orcid.org/0000-0002-4916-1177
Lips, Esther H. http://orcid.org/0000-0003-3488-4935
Mayayo-Peralta, Isabel
Mulder, Lennart
Kristel, Petra
van der Heijden, Ingrid http://orcid.org/0000-0003-2849-8253
Annunziato, Stefano
van Seijen, Maartje http://orcid.org/0000-0002-9348-239X
Nederlof, Petra M. http://orcid.org/0000-0002-2358-9765
Sonke, Gabe S.
Zwart, Wilbert
Wesseling, Jelle http://orcid.org/0000-0002-8940-2676
Wessels, Lodewyk F. A.
Funding for this research was provided by:
KWF Kankerbestrijding (2014-6007, 2014-6007, 2014-6007, 2014-6007)
Article History
Received: 6 September 2021
Accepted: 12 April 2022
First Online: 6 May 2022
Competing interests
: G.S.S. has received institutional research funding from AstraZeneca, Merck, Novartis, and Roche, all outside the current project. All other authors declare that they have no competing interests.